TY - JOUR
T1 - Effect of tubal sterilization technique on risk of serous epithelial ovarian and primary peritoneal carcinoma
AU - Lessard-Anderson, Collette R.
AU - Handlogten, Kathryn S.
AU - Molitor, Rochelle J.
AU - Dowdy, Sean C.
AU - Cliby, William A.
AU - Weaver, Amy L.
AU - Sauver, Jennifer St
AU - Bakkum-Gamez, Jamie N.
N1 - Publisher Copyright:
© 2014 Elsevier Inc. All rights reserved.
PY - 2014/12/1
Y1 - 2014/12/1
N2 - Objective. To determine the effect of excisional tubal sterilization on subsequent development of serous epithelial ovarian cancer (EOC) or primary peritoneal cancer (PPC). Methods. We performed a population-based, nested case-control study using the Rochester Epidemiology Project. We identified all patients with a diagnosis of serous EOC or PPC from 1966 through 2009. Each case was age-matched to 2 controls without either diagnosis. Odds ratios (ORs) and corresponding 95% CIs were estimated from conditional logistic regression models. Models were adjusted for prior hysterectomy, prior salpingo-oophorectomy, oral contraceptive use, endometriosis, infertility, gravidity, and parity. Results. In total, we identified 194 cases of serous EOC and PPC during the study period and matched them with 388 controls (mean [SD] age, 61.4 [15.2] years). Fourteen cases (7.2%) and 46 controls (11.9%) had undergone tubal sterilization. Adjusted risk of serous EOC or PPC was slightly lower after any tubal sterilization (OR, 0.59 [95% CI, 0.29-1.17]; P = .13). The rate of excisional tubal sterilization was lower in cases than controls (2.6% vs 6.4%). Adjusted risk of serous EOC and PPC was decreased by 64% after excisional tubal sterilization (OR, 0.36 [95% CI, 0.13-1.02]; P = .054) compared with those without sterilization or with nonexcisional tubal sterilization. Conclusions. We present a population-based investigation of the effects of excisional tubal sterilization on the risk of serous EOC and PPC. Excisional methods may confer greater risk reduction than other sterilization methods.
AB - Objective. To determine the effect of excisional tubal sterilization on subsequent development of serous epithelial ovarian cancer (EOC) or primary peritoneal cancer (PPC). Methods. We performed a population-based, nested case-control study using the Rochester Epidemiology Project. We identified all patients with a diagnosis of serous EOC or PPC from 1966 through 2009. Each case was age-matched to 2 controls without either diagnosis. Odds ratios (ORs) and corresponding 95% CIs were estimated from conditional logistic regression models. Models were adjusted for prior hysterectomy, prior salpingo-oophorectomy, oral contraceptive use, endometriosis, infertility, gravidity, and parity. Results. In total, we identified 194 cases of serous EOC and PPC during the study period and matched them with 388 controls (mean [SD] age, 61.4 [15.2] years). Fourteen cases (7.2%) and 46 controls (11.9%) had undergone tubal sterilization. Adjusted risk of serous EOC or PPC was slightly lower after any tubal sterilization (OR, 0.59 [95% CI, 0.29-1.17]; P = .13). The rate of excisional tubal sterilization was lower in cases than controls (2.6% vs 6.4%). Adjusted risk of serous EOC and PPC was decreased by 64% after excisional tubal sterilization (OR, 0.36 [95% CI, 0.13-1.02]; P = .054) compared with those without sterilization or with nonexcisional tubal sterilization. Conclusions. We present a population-based investigation of the effects of excisional tubal sterilization on the risk of serous EOC and PPC. Excisional methods may confer greater risk reduction than other sterilization methods.
KW - Fimbriectomy
KW - Salpingectomy
KW - Serous ovarian cancer
KW - Serous primary peritoneal cancer
KW - Tubal sterilization
UR - http://www.scopus.com/inward/record.url?scp=84920720655&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84920720655&partnerID=8YFLogxK
U2 - 10.1016/j.ygyno.2014.10.005
DO - 10.1016/j.ygyno.2014.10.005
M3 - Article
C2 - 25316178
AN - SCOPUS:84920720655
SN - 0090-8258
VL - 135
SP - 423
EP - 427
JO - Gynecologic Oncology
JF - Gynecologic Oncology
IS - 3
ER -